Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. KMDA
KMDA logo

KMDA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Kamada Ltd (KMDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.500
1 Day change
-2.60%
52 Week Range
9.350
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

KMDA is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 and an impatient entry preference. The stock lacks a strong bullish technical setup, has no recent news catalyst, no strong proprietary buy signal, and no clear financial snapshot to support a confident long-term entry. Based on the current data, the better call is to wait rather than buy immediately.

Technical Analysis

KMDA is trading pre-market at 7.86, very close to its pivot level of 7.823. The MACD histogram is slightly negative and contracting, which suggests weak momentum rather than a strong uptrend. RSI_6 at 44.4 is neutral-to-soft, and the moving averages are converging, indicating consolidation instead of a decisive breakout. Immediate resistance is near 8.021 and 8.144, while support sits at 7.624 and 7.501. The short-term pattern estimate suggests only modest upside over the next week and month, not enough to justify an aggressive buy for a beginner investor.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish on paper, with a very low put-call ratio in both open interest and volume, implying traders are positioned for upside. However, the absolute option activity is small, and the setup appears more speculative than confirmatory. Implied volatility is extremely high at 231.59, with IV percentile 91.27 and IV rank 63.76, meaning option pricing is expensive and expectations are elevated. This supports bullish sentiment, but not necessarily a clean long-term entry.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
13
Buy
1

Positive Catalysts

  • ["Options positioning is strongly bullish, with put-call ratios near zero.", "Pre-market price is holding near pivot support, which can sometimes precede a move higher if buyers step in.", "Short-term pattern estimate shows positive expected moves over the next week and month.", "No recent negative news was reported in the last week."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no event-driven catalyst currently visible.", "MACD is below zero and still negatively contracting, pointing to weak momentum.", "RSI is neutral at 44.4, showing no strong buying pressure.", "Moving averages are converging, which signals indecision rather than trend strength.", "No recent significant hedge fund or insider activity.", "No recent congress trading data.", "Financial snapshot data was unavailable, limiting confidence in the fundamental outlook."]

Financial Performance

Latest quarter season could not be assessed because the financial snapshot returned an error and no quarter results were provided. As a result, there is no usable revenue, earnings, or growth trend information to confirm strong long-term fundamental momentum.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no evidence of a recent Wall Street upgrade/downgrade trend. The Wall Street pros view is therefore neutral at best: there is no visible bullish analyst consensus to support an immediate long-term buy, and no meaningful bearish downgrade trend either.

Wall Street analysts forecast KMDA stock price to rise
2 Analyst Rating
Wall Street analysts forecast KMDA stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 7.700
sliders
Low
13
Averages
14
High
15
Current: 7.700
sliders
Low
13
Averages
14
High
15
H.C. Wainwright
Buy
maintain
$11 -> $13
AI Analysis
2025-12-09
Reason
H.C. Wainwright
Price Target
$11 -> $13
AI Analysis
2025-12-09
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Kamada to $13 from $11 and keeps a Buy rating on the shares. The company decided to discontinue its Phase 3 inhaled alpha-1 antitrypsin deficiency clinical trial based on the results of the planned interim futility analysis, the analyst tells investors in a research note. The firm says the decision helps to refocus the company on its core products and eliminates a "long over-hanging distraction that was unlikely to be fruitful."

People Also Watch